Skip to main content

LBMC Unveils Key Healthcare Trends for 2025: AI, M&A, Cybersecurity, and Policy Shifts Poised to Reshape the Industry

Written by Customer Service on . Posted in Mergers And Acquisitions.

AI, Innovation, and the Future of Healthcare in 2025

As AI adoption accelerates, healthcare organizations must navigate emerging technologies while ensuring data security and compliance.
As AI adoption accelerates, healthcare organizations must navigate emerging technologies while ensuring data security and compliance.

Nashville, Tenn., Feb. 26, 2025 (GLOBE NEWSWIRE) — As the healthcare landscape continues to evolve, industry leaders are facing a convergence of rapid innovation, regulatory shifts, and heightened cybersecurity concerns. Matt Cybulsky, LBMC Healthcare AI and Product Innovation expert, highlights key trends shaping 2025, including AI’s expanding role in diagnostics, an anticipated surge in mergers and acquisitions, and the increasing pressure on healthcare organizations to integrate technology while safeguarding sensitive data. 

 

Key Healthcare Trends for 2025

  •  AI’s Growing Contribution to Personalized Care and Diagnostics 
    AI-driven technologies are improving healthcare procedures, customized treatment regimens, and diagnostics. AI-assisted imaging enhances decision-making, efficiency, and predictive analytics. It is anticipated that automation will also transform administrative duties and responsibilities.
  • The Year of Mergers and Acquisitions (M&A) 
    Digital health, biotech, and provider groups are seeing more M&A activity as companies seek scale, data integration, and new care models. Meanwhile, private equity-backed consolidations in healthcare services remain under close watch. Regulatory changes and a new administration are bound to impact hospital and tech acquisitions, including market consolidation. 

“The anticipated resurgence in healthcare M&A for 2025 is driven by declining interest rates, significant PE investor ‘dry powder,’ and a more lenient regulatory environment, paving the way for transformative deals that could redefine patient care and industry standards,” says Lisa Nix, LBMC Shareholder and Practice Leader, Transaction Advisory Services. 

  • GLP-1s, SGLT-2s, and the New Era of Consumer-Focused Healthcare 
    Despite the incredible advantages of these medications, demand has sparked worries about supply shortages, insurance coverage, and price. Conversations are dominated by alternative access models and weight-loss platforms that place a greater emphasis on appearance and makeup. As 2025 progresses, access and costs will be impacted by coverage for these from all payors, including the government. 
  • Decision Support Tools Rooted in AI for 2025 
    Multi-function decision support tools, including text, imaging, genomic data, and patient history, enhance diagnostic capability and, ultimately, efficiency.  
  • Possible Effects of the New Administration on Healthcare Policy 
    Key discussions include Medicare and Medicaid policy, AI regulation, and medication pricing negotiations. Leaders are closely observing how healthcare economics will be affected by CMS, HHS, and FTC decisions. 
  • Integration of AI to Address Staffing and Continued Workforce Challenges 
    AI-powered scheduling, clinical documentation tools, and virtual assistants are already in use, with further expansion expected in nursing, radiology, and primary care. The rise of digital hospitals is set to reshape healthcare delivery across the industry as challenges for the workforce continue to mount.
  • AI and Healthcare Cybersecurity Vendor Risk
    Healthcare cybersecurity is crucial as AI adoption rises and firms continue their digital transformations.

“With growing reliance on AI, data architecture is changing, data repositories are multiplying, new identities are being created, and our overall threat surface is expanding. Healthcare organizations must embed cybersecurity into digital transformation efforts to harness AI’s potential while also protecting critical data,” says Van Steel, LBMC Shareholder and Healthcare Cybersecurity Leader. 

 

Key Healthcare Leader Considerations: 

 

  • AI: Risk & Opportunity — AI improves efficiency but creates new vulnerabilities. Healthcare data must be protected by GenAI policies. Vendors must disclose AI’s role in handling PHI and ensure HIPAA compliance. 
  • Supplier Contracts — Many SaaS systems now use AI, but contracts signed before late 2022 may not safeguard AI. Leaders must reevaluate agreements for accountability. 
  • PE-backed healthcare enterprises need cybersecurity. 
  • Regulatory & Insurance Pressures — Rising cyber risks are driving stricter compliance. Neglecting AI security could result in financial and reputational damage. 

“As AI becomes increasingly integral to healthcare, organizations must balance its transformative potential with rising cybersecurity threats and ever-changing regulations. Those that master this balance—leveraging AI while safeguarding data security, ensuring high data quality, and maintaining compliance—will lead the industry forward,” says Jon Hilton, LBMC Shareholder and Practice Leader, Consulting and Business Intelligence. 

 

Get insights on the future of healthcare and how your organization can adapt by downloading our 2025 Business Outlook Report today.  

 

For more insights or to connect with LBMC’s healthcare industry experts, visit our website. 

 

About LBMC  

LBMC is one of the Southeast’s largest accounting and business consulting firms and an Accounting Today Top 40 Firm in the Nation serving more than 11,000 clients with diverse needs across a spectrum of industries. Primary client groups include privately-owned and private-equity-backed middle market companies in the healthcare, manufacturing/distribution, real estate, and technology spaces. At the forefront of innovation, LBMC leverages advanced business intelligence and AI technologies to drive growth, efficiency, and strategic insights for our clients. Founded in 1984 as a traditional accounting firm, LBMC today is an industry leader in audit, tax, advisory, technology, human resources, and wealth advisory services for businesses and individuals. LBMC has more than 900 team members, with offices in Nashville, Chattanooga, Knoxville, and Memphis, Tennessee; Louisville, Kentucky; and Charlotte, North Carolina and remote offices. For more information on LBMC’s experts and comprehensive services, visit our website or call 615.377.4600. Discover career opportunities or learn more about how LBMC’s services and culture can support your business goals. Connect with us on LinkedIn for the latest insights on talent, client engagement, and business growth.

Attachment

CONTACT: Lisa Namm
LBMC
6153092356
lisa.namm@lbmc.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.